T cells and inflammatory cytokine networks

T cells and inflammatory cytokine networks represent the complex, multi-component system of T-lymphocytes and the signaling proteins they produce to orchestrate immune responses. This network involves various T-cell subsets, such as Th1, Th2, Th17, and regulatory T cells, which interact via cytokines like TNF-alpha, IL-6, IL-17, and IFN-gamma to maintain homeostasis or drive inflammation (Nature Reviews Immunology, 2018). In many autoimmune and chronic inflammatory diseases, these networks become dysregulated, leading to persistent tissue damage and pathology (Frontiers in Immunology, 2020). While the network as a whole is not a single molecular target, its specific nodes—including individual cytokines, their receptors, and intracellular signaling molecules like Janus kinases (JAKs)—are the focus of numerous therapeutic interventions (PubMed, 2021). Drugs targeting these networks, such as monoclonal antibodies and small molecule inhibitors, aim to restore immune balance by dampening overactive inflammatory signals.

Other names

T-cell signaling pathwaysCytokine-mediated immune networksT-lymphocyte inflammatory axis

Modulation of the network through cytokine neutralization, receptor antagonism, or inhibition of intracellular signal transduction pathways.